L. De Luca

415 total citations
18 papers, 328 citations indexed

About

L. De Luca is a scholar working on Transplantation, Psychiatry and Mental health and Surgery. According to data from OpenAlex, L. De Luca has authored 18 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Transplantation, 7 papers in Psychiatry and Mental health and 6 papers in Surgery. Recurrent topics in L. De Luca's work include Neurological Complications and Syndromes (7 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). L. De Luca is often cited by papers focused on Neurological Complications and Syndromes (7 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). L. De Luca collaborates with scholars based in Italy, United Kingdom and United States. L. De Luca's co-authors include Giuseppe Iaria, Giuseppe Orlando, Giuseppe Tisone, M. Angélico, Tommaso Maria Manzia, Alessandro Anselmo, Andrea Cardillo, Laura Tariciotti, Luca Toti and Marialuisa Framarino‐dei‐Malatesta and has published in prestigious journals such as Transplantation, Powder Technology and Liver Transplantation.

In The Last Decade

L. De Luca

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. De Luca Italy 11 134 120 94 61 58 18 328
Bernard Ellero France 12 178 1.3× 100 0.8× 203 2.2× 162 2.7× 43 0.7× 42 441
Aydın Dalgıç Türkiye 11 230 1.7× 90 0.8× 172 1.8× 83 1.4× 81 1.4× 62 407
Bynvant Sandhu United Kingdom 11 175 1.3× 82 0.7× 110 1.2× 66 1.1× 74 1.3× 24 370
Devon John United States 9 204 1.5× 100 0.8× 102 1.1× 51 0.8× 91 1.6× 29 393
Mohammed F. Shaheen Saudi Arabia 8 105 0.8× 75 0.6× 62 0.7× 57 0.9× 27 0.5× 21 223
A. McLean United Kingdom 10 139 1.0× 318 2.6× 40 0.4× 51 0.8× 68 1.2× 16 508
Adele Rike United States 7 341 2.5× 629 5.2× 48 0.5× 95 1.6× 80 1.4× 11 761
G.F. Zanon Italy 8 83 0.6× 58 0.5× 43 0.5× 64 1.0× 58 1.0× 25 281
Donata Cresseri Italy 10 57 0.4× 82 0.7× 25 0.3× 35 0.6× 27 0.5× 40 356
Isabel Roberti United States 10 116 0.9× 153 1.3× 19 0.2× 40 0.7× 56 1.0× 22 306

Countries citing papers authored by L. De Luca

Since Specialization
Citations

This map shows the geographic impact of L. De Luca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. De Luca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. De Luca more than expected).

Fields of papers citing papers by L. De Luca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. De Luca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. De Luca. The network helps show where L. De Luca may publish in the future.

Co-authorship network of co-authors of L. De Luca

This figure shows the co-authorship network connecting the top 25 collaborators of L. De Luca. A scholar is included among the top collaborators of L. De Luca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. De Luca. L. De Luca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
3.
Framarino‐dei‐Malatesta, Marialuisa, Martina Derme, Tommaso Maria Manzia, et al.. (2013). Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Expert Review of Clinical Immunology. 9(8). 781–789. 34 indexed citations
4.
Bellini, Maria Irene, Giuseppe Iaria, L. De Luca, et al.. (2012). Emergency Endovascular Repair in a Patient With Abdominal Aortic Aneurysm With Pelvic Transplant Kidneys: Case Report. Experimental and Clinical Transplantation. 10(6). 601–604. 7 indexed citations
5.
Cocco, Pierpaolo Di, et al.. (2011). Kidney Transplantation From Older Donors. Transplantation Proceedings. 43(4). 1033–1035. 10 indexed citations
6.
Iaria, Giuseppe, D. Sforza, Roberta Angelico, et al.. (2011). Switch from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Kidney Transplantation. Transplantation Proceedings. 43(4). 1028–1029. 12 indexed citations
7.
Framarino‐dei‐Malatesta, Marialuisa, L. De Luca, Bianca Rocca, et al.. (2011). Successful Pregnancy in a Living-Related Kidney Transplant Recipient Who Received Sirolimus Throughout the Whole Gestation. Transplantation. 91(9). e69–e71. 31 indexed citations
8.
Manuelli, Matteo, L. De Luca, Giuseppe Iaria, et al.. (2010). Conversion to Rapamycin Immunosuppression for Malignancy After Kidney Transplantation. Transplantation Proceedings. 42(4). 1314–1316. 35 indexed citations
9.
Iaria, Giuseppe, F Pisani, L. De Luca, et al.. (2010). Prospective Study of Switch From Cyclosporine to Tacrolimus for Fibroadenomas of the Breast in Kidney Transplantation. Transplantation Proceedings. 42(4). 1169–1170. 7 indexed citations
10.
Lionetti, Raffaella, Giuseppe Tisone, Giampiero Palmieri, et al.. (2009). Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Digestive and Liver Disease. 42(4). 297–303. 8 indexed citations
11.
Iaria, Giuseppe, Alessandro Anselmo, L. De Luca, et al.. (2007). Conversion to Rapamycin Immunosuppression for Malignancy After Kidney Transplantation: Case Reports. Transplantation Proceedings. 39(6). 2036–2037. 17 indexed citations
12.
Baiocchi, Leonardo, M. Angélico, L. De Luca, et al.. (2006). Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transplant International. 19(5). 389–395. 6 indexed citations
13.
Orlando, Giuseppe, Leonardo Baiocchi, Andrea Cardillo, et al.. (2006). Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension. Liver Transplantation. 13(1). 46–54. 64 indexed citations
14.
Iaria, Giuseppe, F Pisani, Carlo Lucchesi, et al.. (2006). Long-Term Results of Kidney Transplantation With Cyclosporine- and Everolimus-Based Immunosuppression. Transplantation Proceedings. 38(4). 1018–1019. 3 indexed citations
15.
Manzia, Tommaso Maria, Nicola de Liguori Carino, Giuseppe Orlando, et al.. (2005). Use of Mycophenolate Mofetil in Liver Transplantation: A Literature Review. Transplantation Proceedings. 37(6). 2616–2617. 31 indexed citations
16.
Orlando, Giuseppe, L. De Luca, Luca Toti, et al.. (2004). Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplantation Proceedings. 36(1). 199–202. 31 indexed citations
17.
Pisani, F, Oreste Claudio Buonomo, Giuseppe Iaria, et al.. (2004). Sirolimus in kidney transplantation from marginal donors. Transplantation Proceedings. 36(3). 495–496. 11 indexed citations
18.
Luca, L. De, et al.. (1992). Slugging behaviour of fluidized beds of large particles. Powder Technology. 69(2). 171–175. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026